Gene therapy and imaging of transgene expression in living subjects

Molecular Imaging with Reporter Genes

Volumn , Issue , 2010, Pages 227-238

  Yaghoubi, Shahriar S ^a   Gambhir, Sanjiv Sam ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOLOGY; GENE THERAPY; HISTOLOGY; PATIENT TREATMENT; TISSUE;

CELL TARGETING; ENDOGENOUS GENES; GENETIC MATERIALS; TARGET TISSUES; THERAPEUTIC OUTCOMES; THERAPEUTIC PROCEDURES; THERAPEUTIC TRANSGENE; TRANSGENE EXPRESSION;

GENE EXPRESSION;

EID: 84864530380     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511730405.010     Document Type: Chapter

References (61)

1. Gao, X., Kim, K., Liu, D. (2007). Nonviral gene delivery: What we know and what is next. AAPS Journal 9(1): E92–E104.
2. De, A., Gambhir, S. S. (2003). PET in imaging gene expression and therapy. In: Bailey, D. et al. (Eds.), Positron Emission Tomography: Basic Science and Clinical Practice, New York: Springer-Verlag: 845–868.
3. Min, J. J., Gambhir, S. S. (2004).Gene therapy progress and prospects: noninvasive imaging of gene therapy in living subjects. Gene Therapy 11: 115–125.
4. Walls, Z., Gambhir, S. S. (2007). BRET-based method for detection of specific RNA species. Bioconjug Chem 19(1): 178–184.
5. Walls, Z. et al. (2008). A generalizable strategy for imaging pre-mRNA levels in living subjects using spliceosomemediated RNA trans-splicing. J Nucl Med 49(7): 1146–1154.
6. Yaghoubi, S. S., Gambhir, S. S. (2008). Imaging and cancer. In: Mendelsohn, J. et al. (Eds.), The Molecular Basis of Cancer. Saunders Elsevier: Philadelphia: 309–323.
7. Tarantal, A. F. et al. (2006). Fetal gene transfer using lentiviral vectors: In vivo detection of gene expression by microPET and optical imaging in fetal and infantmonkeys. Hum Gene Ther 17: 1254–1261.
8. Chaudhuri, T. R. et al. (2001). A noninvasive reporter systemto image adenoviral-mediated gene transfer to ovarian cancer xenografts. Gynecol Oncol 83: 432–438.
9. Xiong, Z. et al. (2006). Imaging chemically modified adenovirus for targeting tumors expressing integrin avb3 in living mice withmutant herpes simplex virus type 1 thymidine kinase PET reporter gene. J Nucl Med 47(1): 130–139.
10. Wu, J. C. et al. (2002). Positron emission tomography imaging of cardiac reporter gene expression in living rats. Circulation 106: 180–183.
11. Richard, J.-C. et al. (2003). Imaging the spatial distribution of transgene expression in the lungswith positron emission tomography. Gene Therapy 10: 2074–2080.
12. Deroose, C. M. et al. (2006). Noninvasive monitoring of long-term lentiviral vector-mediated gene expression in rodent brain with bioluminescence imaging. Mol Ther 14(3): 423–431.
13. Lim, S. J. et al. (2007). Enhanced expression of adenovirusmediated sodium iodide symporter gene in MCF-7 breast cancer cells with retinoic acid treatment. J Nucl Med 48(3): 398–404.
14. Kuruppu, D. et al. (2007). Positron emission tomography of herpes simplex virus 1 oncolysis. Cancer Research 67(7): 3295–3300.
15. Sen, L. et al. (2005). Noninvasive imaging of ex vivo intracoronarily delivered nonviral therapeutic transgene expression in heart. Mol Ther 12(1): 49–57.
16. Hildebrandt, I. J. et al. (2003). Optical imaging of transferrin targeted PEI/DNA complex in living subjects. Gene Therapy 10: 758–764.
17. De, A., Lewis, X. Z., Gambhir, S. S. (2003). Noninvasive imaging of lentiviral-mediated reporter gene expression in living mice. Mol Ther 7(5): 681–691.
18. Jacobs, A. et al. (2001). Positron emission tomographybased imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo. Cancer Research 61: 2983–2995.
19. Bennett, J. J. et al. (2001). Positron emission tomography imaging for herpes virus infection: Implications for oncolytic viral treatments of cancer. Nat Med 7(7): 859–863.
20. Yaghoubi, S. S. et al. (2005). Imaging progress of herpes simplex virus type 1 thymidine kinase suicide gene therapy in living subjects with positron emission tomography. Cancer Gene Therapy 12: 329–339.
21. Pantuck, A. J. et al. (2002).CL1-SR39:Anoninvasive molecular imaging model of prostate cancer suicide gene therapy using positron emission tomography. J Urol 168: 1193–1198.
22. Pantuck, A. J. et al. (2002). Optimizing prostate cancer suicide gene therapy using herpes simplex virus thymidine kinase active site variants. HumGene Ther 13: 777–789.
23. Burton, J. B. et al. (2008). Adenovirus-mediated gene expression imaging to directly detect sentinel lymph node metastasis of prostate cancer. Nat Med 14(8): 882–888.
24. Deng, W. et al. (2004). Non-invasive in vivo imaging with radiolabelled FIAU for monitoring cancer gene therapy using herpes simplex virus type 1 thymidine kinase and ganciclovir. Eur J Nucl Med Mol Imaging 31(1): 99–109.
25. Wang, H. et al (2006).Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and Ganciclovir prodrug activation gene therapy of cancer. J Nucl Med 47: 1161–1171.
26. Deng, W. et al (2006). Serial in vivo imaging of lung metastases model and gene therapy using HSV1-tk and Ganciclovir. J Nucl Med 47: 877–884.
27. Penuelas, I. et al. (2005). Gene therapy imaging in patients for oncological applications. Eur J Nucl Med Mol Imaging 32(14): S384–S403.
28. Yaghoubi, S. S. et al. (2001). Human pharmacokinetic and dosimetry studies of [18F]FHBG: a reporter probe for imaging herpes simplex virus type-1 thymidine kinase reporter gene expression. J Nucl Med 42: 1225–1234.
29. Yaghoubi, S. S. et al. (2006). Preclinical safety evaluation of 18F-FHBG: A PET reporter probe for imaging herpes simplex virus type 1 thymidine kinase (HSV1-tk) ormutant HSV1-sr39tk's expression. J Nucl Med 47(4): 706–715.
30. Penuelas, I. et al. (2005). Positron emission tomography imaging of adenoviral-mediated transgene expression in liver cancer patients. Gastroenterology 128(7): 1787–1795.
31. Jacobs, A. et al. (2001). Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet 358: 727–729.
32. Dempsey, M. F. et al. (2006). Assessment of 123I-FIAU imaging of herpes simplex viral gene expression in the treatment of glioma. Nucl Med Commun 27: 611–617.
33. Yaghoubi, S. S. et al. Noninvasive detection of therapeutic cytolytic T cells with 18F-FHBG in a patient with glioma. Nat Clin Pract Oncol 6: 53–58.
34. Chin, F. T. et al. (2008). Semiautomated radiosynthesis and biological evaluation of [18F]FEAU: a novel PET imaging agent for HSV1-tk/sr39tk reporter gene expression. Mol Imaging Biol 10(2): 82–91.
35. Alauddin, M. M., Conti, P. S. (1998). Synthesis and preliminary evaluation of 9-(4-[18F]-Fluoro-3- Hydroxymethylbutyl)Guanine ([18F]FHBG): anewpotential imaging agent for viral infection and gene therapy using PET. Nucl Med Biol 25: 175–180.
36. Alauddin, M. A. et al. (2001). Preclinical evaluation of the penciclovir analog 9-(4-[18F]fluoro-3-hydroxymethylbutyl) guanine for in vivo measurement of suicide gene expression with PET. J Nucl Med 42(11): 1682–1690.
37. Ray, P. et al. (2001).Monitoring gene therapy with reporter gene imaging. Semin Nucl Med 31(4): 312–320.
38. Iyer, M. et al (2005). Applications ofmolecular imaging in cancer gene therapy. Curr Gene Ther 5: 607–618.
39. Gambhir, S. S. et al. (2000). Imaging transgene expression with radionuclide imaging technologies. Neoplasia 2(1–2): 118–138.
40. Herschman, H. R. et al. (2002). Monitoring gene therapy by positron emission tomography. In: Curiel, D. T., and Douglas, J. T. (Eds.), Vector Targeting for Therapeutic Gene Delivery 661–685.Wiley-Liss: New York.
41. Yaghoubi, S. S. et al. (2001). Direct correlation between positron emission tomographic images of two reporter genes delivered by two distinct adenoviral vectors. Gene Therapy 8: 1072–1080.
42. Yu, Y. et al. (2000).Quantification of target gene expression by imaging reporter gene expression in living animals. Nat Med 6(8): 933–937.
43. Liang, Q. et al. (2002).Noninvasive, repetitive, quantitative measurement of gene expression froma bicistronic message by positron emission tomography, following gene transfer with adenovirus. Mol Ther 6(1): 73–82.
44. Wang, Y. et al. (2005). Noninvasive monitoring of target gene expression by imaging reporter gene expression in living animals using improved bicistronic vectors. J Nucl Med 46: 667–674.
45. Chen, I. Y. et al. (2004). Micro–positron emission tomography imaging of cardiac gene expression in rats using bicistronic adenoviral vector-mediated gene delivery. Circulation 109: 1415–1420.
46. Tjuvajev, J. G. et al. (1999). A general approach to the non-invasive imaging of transgenes using cis-linked herpes simplex virus thymidine kinase. Neoplasia 1: 315–320.
47. Chappell, S. A., Edelman, G. M., Mauro, V. P. (2000). A 9- nt segment of a cellular mRNA can function as an Internal Ribosome Entry Site (IRES) and when present in linked multiple copies greatly enhances IRES activity. PNAS 97(4): 1536–1541.
48. Anton, M. et al. (2004). Coexpression of herpesviral thymidine kinase reporter gene and VEGF gene for noninvasive monitoring of therapeutic gene transfer: an in vitro evaluation. J Nucl Med 45(10): 1743–1746.
49. Yaghoubi, S. S., Gambhir, S. S. (2003). Monitoring p53 therapeutic transgene expression in mice by imaging the expression of a linked HSV1-sr39tk PET reporter transgene. J Nucl Med 44(5): 30P [Abstract#95].
50. Sun, X. et al. (2001). Quantitative imaging of gene induction in living animals. Gene Therapy 8: 1572–1579.
51. Ray, S. et al. (2004). Novel bidirectional vector strategy for amplification of therapeutic and reporter gene expression. Hum Gene Ther 15: 681–690.
52. Ray, P. et al. (2004). Imaging tri-fusion multimodality reporter gene expression in living subjects. Cancer Research 64: 1323–1330.
53. Ray, P., Tsien, R., Gambhir, S. S. (2007). Construction and validation of improved triple fusion reporter gene vectors for molecular imaging of living subjects. Cancer Research 67(7): 3085–3093.
54. Ray, P., Wu, A. M., Gambhir, S. S. (2003). Optical bioluminescence and positron emission tomography imaging of a novel fusion reporter gene in tumor xenografts of living mice. Cancer Research 63: 1160–1165.
55. Doubrovin, M. et al Development of a new reporter gene system-dsRed/Xanthine Phosphoribosyltransferase- Xanthine for molecular imaging of processes behind the intact blood–brain barrier. Mol Imaging 2(2): 93–112.
56. Ponomarev, V. et al. (2004). A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging. Eur JNuclMedMol Imaging 31: 740–751.
57. Jacobs, A. et al. (1999). Functional coexpression of HSV-thymidine kinase and green fluorescent protein: implications for noninvasive imaging of transgene expression. Neoplasia 1(2): 154–161.
58. Hwang, D. W. et al. Development of a dual membrane protein reporter system using sodium iodide symporter and mutant dopamine D2 receptor transgenes. J Nucl Med 48(4): 588–595.
59. Doubrovin, M. et al. (2001). Imaging transcriptional regulation of p53-dependent genes with positron emission tomography in vivo. PNAS 98(16): 9300–9305.
60. Green, L. A. et al. (2002). Indirect monitoring of endogenous gene expression by positron emission tomography (PET) imaging of reporter gene expression in transgenic mice. Mol Imaging Biol 4(1): 71–81.
61. Green, L. A. et al. (2004). A tracer kinetic model for 18FFHBG for quantitating herpes simplex virus type 1 thymidine kinase reporter gene expression in living animals using PET. J Nucl Med 45(9): 1560–1570.